- Home
- TARS vs RXRX Comparison
TARS vs RXRX Comparison
Compare TARS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- RXRX
- Stock Information
- Founded
- TARS 2016
- RXRX 2013
- Country
- TARS United States
- RXRX United States
- Employees
- TARS N/A
- RXRX N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TARS Health Care
- RXRX Health Care
- Exchange
- TARS Nasdaq
- RXRX Nasdaq
- Market Cap
- TARS 1.8B
- RXRX 2.0B
- IPO Year
- TARS 2020
- RXRX 2021
- Fundamental
- Price
- TARS $44.83
- RXRX $6.18
- Analyst Decision
- TARS Strong Buy
- RXRX Buy
- Analyst Count
- TARS 5
- RXRX 6
- Target Price
- TARS $54.20
- RXRX $9.40
- AVG Volume (30 Days)
- TARS 1.1M
- RXRX 5.5M
- Earning Date
- TARS 11-13-2024
- RXRX 11-06-2024
- Dividend Yield
- TARS N/A
- RXRX N/A
- EPS Growth
- TARS N/A
- RXRX N/A
- EPS
- TARS N/A
- RXRX N/A
- Revenue
- TARS $129,621,000.00
- RXRX $65,184,000.00
- Revenue This Year
- TARS $852.60
- RXRX $50.69
- Revenue Next Year
- TARS $74.21
- RXRX $40.10
- P/E Ratio
- TARS N/A
- RXRX N/A
- Revenue Growth
- TARS 801.96
- RXRX 37.64
- 52 Week Low
- TARS $15.60
- RXRX $5.89
- 52 Week High
- TARS $52.99
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- TARS 57.98
- RXRX 41.15
- Support Level
- TARS $46.22
- RXRX $6.68
- Resistance Level
- TARS $52.99
- RXRX $8.49
- Average True Range (ATR)
- TARS 3.62
- RXRX 0.51
- MACD
- TARS -0.33
- RXRX -0.02
- Stochastic Oscillator
- TARS 42.09
- RXRX 1.07
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.